Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EZH2 | Q15910 | 20/20 | 0.48 |
| ▸ | EED | O75530 | 13/20 | 0.48 |
| ▸ | RBBP4 | Q09028 | 13/20 | 0.48 |
| ▸ | SUZ12 | Q15022 | 13/20 | 0.48 |
| ▸ | RBBP7 | Q16576 | 1/20 | 0.48 |
| ▸ | AEBP2 | Q6ZN18 | 12/20 | 0.46 |
| ▸ | EZH1 | Q92800 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1694843 | 0.77 | EZH2 (0.46) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL1695610 | 0.77 | EZH2 (0.54) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL1694768 | 0.72 | EZH2 (0.73) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL27983811 | 0.71 | EZH2 (0.62) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL13467755 | 0.69 | EZH2 (0.55) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL1695481 | 0.69 | EZH2 (0.85) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL17026076 | 0.68 | EZH2 (0.54) | EZH2EEDRBBP4SUZ12AEBP2 | |
| SCHEMBL12180083 | 0.68 | EZH2 (0.85) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL12180703 | 0.68 | EZH2 (0.85) | EZH2EEDRBBP4SUZ12RBBP7 | |
| SCHEMBL14972054 | 0.68 | EZH2 (0.54) | EZH2EEDRBBP4SUZ12AEBP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2566479-A1 | AZAINDAZOLES | GlaxoSmithKline LLC (US) | 2013-03-13 | — | — | EP | disclosed |
| WO-2012005805-A1 | AZAINDAZOLES | GLAXOSMITHKLINE LLC (US) | 2012-01-12 | — | — | WO | disclosed |